Genome Mining and Comparative Analysis of Secondary Metabolite Biosynthetic Gene Clusters in Selected Streptomyces Species Reported from Indian Biodiversity Hotspots
Oct 2026· International Journal of Drug Delivery Technology· Vol 16· 0 citations
TL;DR
A comparative genome mining analysis was conducted on selected Streptomyces species reported by various research groups from Indian biodiversity hotspots, indicating possibility of novel natural products that can converted to drugs.
Abstract
Actinomycetes, particularly the genus Streptomyces, represents most prolific sources of bioactive secondary metabolites
(antibiotics, anticancer agents, immunosuppressants and other therapeutic molecules). Advances in whole-genome
sequencing and bioinformatics enabled identification of numerous unexplored cryptic biosynthetic gene clusters
(BGCs) In our study, a comparative genome mining analysis was conducted on selected Streptomyces species reported
by various research groups from Indian biodiversity hotspots (Indo-Burma, Himalayan, Sundaland and Western Ghats).
Whole genome sequences were retrieved from NCBI GenBank and analyzed using antiSMASH for prediction and
annotation of secondary metabolite BGCs. Comparative analysis using MIBiG and related databases predicted potential
metabolites and revealed diverse classes of BGCs including Type I, Type II and Type III polyketide synthases (PKS),
non-ribosomal peptide synthetases (NRPS), ribosomally synthesized and post-translationally modified peptides (RiPPs),
lanthipeptides, terpenes, siderophores, hybrid PKS-NRPS clusters etc. Indo-Burma isolates exhibited highest diversity
of BGCs, while Himalayan strains showed enrichment of siderophore-associated pathways. Sundaland isolates
possessed abundant RiPP and lanthipeptide clusters, whereas Western Ghats isolates displayed significant terpene
biosynthetic potential. Several gene clusters demonstrated low similarity to characterized MIBiG entries, indicating
possibility of novel natural products that can converted to drugs.
A conserved genomic foundation coupled with extensive diversification of specialized-metabolite biosynthetic repertoires in medicinal plant-associated Diaporthe is revealed and conserved and isolate-restricted BGC families are identified as candidates for future metabolomic and functional characterization.
B. Chellappan, Ashraf Abbass Metwally· Journal of Fungi· 0 citations
Siderochelin A, a monomeric compound isolated from a fermentation product, demonstrated antibacterial efficacy against various pathogenic bacteria, providing a theoretical basis for discovering novel species, exploring secondary metabolites, and developing innovative antibiotics.
Yi-Huang Chen, Lu Wang, Tao Luo et al.· Microorganisms· 0 citations
Fungal endophytes are promising sources of pharmaceutically relevant secondary metabolites, yet the genomic basis of their biosynthetic potential remains poorly characterized. We sequenced the genome of endophyte S23, isolated from healthy Eremostachys isochila, and compared it with 13 reference genomes. ITS, multilocu...
F. Eshboev, Mavjuda Kholikova, A. Khan et al.· Molecules· 0 citations
Fifty streptomycete isolates were recovered from war-impacted soils, of which nine of the most antagonistically active strains were selected for further study based on dual-culture screening against fungi and bacteria. Strains Y15, SK4, SK14 and SK16 displayed the strongest and broadest inhibitory activity, with Y15 pr...
M. Loboda, A. Sylchuk· Achievements and Prospects o...· 0 citations
Forest soils contain diverse microorganisms adapted to plant-derived aromatic compounds released during lignin decomposition. Genome-based characterization of these microorganisms provides insights into their genomic diversity and metabolic potential. In this study, strain APP145 was isolated from forest soil usi...
S. Choi, Jun-Ho Yim, Kozhir Karim Abdalla et al.· BMC Genomic Data· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.